Dieulafoy’s lesions are rare vascular malformations of the gastrointestinal tract. Dieulafoy’s lesion was first reported by Gallard in 1884 and then described in detail by Georges Dieulafoy in 1898. A Dieulafoy’s lesion is an aberrant vessel that does not reduce in caliber when it extends from the submucosa to the mucosa. Damage to this artery can cause severe and intermittent arterial bleeding from small vascular stumps that are difficult to visualize. Multiple factors have been proposed that increase the risk of upper gastrointestinal bleeding in end-stage renal disease patients including platelet dysfunction due to uremia, high prevalence of arteriovenous malformations, various co-morbidities like cardiovascular disease, diabetes mellitus, liver cirrhosis and old age. Furthermore, these catastrophic bleeding episodes frequently result in hemodynamic instability and the need for transfusion of multiple blood products. Recently, uremic syndrome has been identified as a risk factor for gastric mucosal lesions. We present two clinical cases of acute digestive bleeding due to the Dielafoy lesion with chronic kidney disease as the main cause, where two different therapies were performed endoscopically. Endoscopic therapy is still the first-line diagnostic and/or treatment option for Dieulafoy’s lesion. This study concluded with the results of the patients that the best therapy was the application of the hemostatic hemoclip on the injury vs. the injection with adrenaline on the wound site. Uremia is identified as a risk factor for upper gastrointestinal bleeding in patients with pre-existing Dieulafoy lesions, as well as a higher incidence of new bleeding.
Author
(s) Details
Gustavo
Adolfo Hernández Valdez
Department of Internal Medicine, ISSSTE APP General Hospital of
Tepic, Tepic, Nayarit, Mexico.
Diana
Estefanía Ibarra García
Department of Internal Medicine, ISSSTE APP General Hospital of
Tepic, Tepic, Nayarit, Mexico.
Juan
Antonio Contreras Escamilla
Department of Internal Medicine, ISSSTE APP General Hospital of
Tepic, Tepic, Nayarit, Mexico.
Janette
Alejandra Gamiño Gutierrez
Hospital Civil de Guadalajara Fray, Mexico.
Francisco
Manuel Tonatiuh Carrillo Beltran
Department of Internal Medicine, ISSSTE APP General Hospital of
Tepic, Tepic, Nayarit, Mexico.
Ulises
Solis Gomez
Department of Internal Medicine, ISSSTE APP General Hospital of Tepic,
Tepic, Nayarit, Mexico.
Jocelyn
Nataly Quintero Meléndez
Department of Internal Medicine, ISSSTE APP General Hospital of
Tepic, Tepic, Nayarit, Mexico.
Ivan
Alejandro Medina Jimenez
Department of Internal Medicine, ISSSTE APP General Hospital of Tepic,
Tepic, Nayarit, Mexico.
Marco
Antonio González Villar
Department of Internal Medicine, ISSSTE APP General Hospital of
Tepic, Tepic, Nayarit, Mexico.
Jorge
Rojas Morales
Department of Internal Medicine, ISSSTE APP General Hospital of
Tepic, Tepic, Nayarit, Mexico.
Please see the book here:- https://doi.org/10.9734/bpi/mmrnp/v4/2410
